Error message

User warning: The following module is missing from the file system: admin_menu. For information about how to fix this, see the documentation page. in _drupal_trigger_error_with_delayed_logging() (line 1138 of /mnt/stor8-wc1-dfw1/408138/

Cannalink, Inc.

First, the Company plans to develop and manufacture a cannabidiol (CBD)-based product for initial distribution to healthcare practitioners. In furtherance of this strategy, the Company completed the acquisition of the MigraSpray product line and assets for $300,000. MigraSpray is a sublingually administered formula for the effective treatment and prevention of migraine headaches, which is distributed through approximately 5,000 healthcare practitioners. The Company plans to use the MigraSpray technology to develop its CBD-based product and to initially market the product through MigraSpray's practitioner distribution platform. Secondly, the Company intends to offer investment banking, merchant banking and business consulting services to emerging companies in the medical marijuana and industrial hemp sector.
Company Overview
Stock Overview